Umbilical Cord Mesenchymal Stem Cell Therapy for Heart Attacks

Tahapan Penelitian : Recruit
Sponsor:
Mitra Pelaksana:
Not Specified
No Registry
INA-84N5CF87
Tanggal Input Registry : 31-01-2025

29-10-2024
infarct size
major adverse cardiac events
 
Umbilical Cord Mesenchymal Stem Cell Therapy for Heart Attacks
Role of Umbilical Cord Mesenchymal Stem Cell Therapy in Reducing Infarct Size in Patients with Acute ST-Elevation Myocardial Infarction Undergoing Percutaneous Coronary Intervention Primary: A Study of IL-10, VEGF, Galectin 3, Gata-4 and Beclin-1
Interventional
PCI + Umbilical cord mesenchymal stem cell, PCI
60
 

Inclusion Criteria:

Patients aged 30-70 years, Patients experiencing STEMI who undergo Primary PCI within a maximum of 12 hours after the onset of chest pain, Patients willing to participate in the study and complete the informed consent form.

Exclusion Criteria:

Patients with a history of coronary artery bypass surgery, Patients with a history of cardiac arrest before hospital admission, Patients with cardiogenic shock, Patients with malignant arrhythmia. Patients with malignancy, Patients with chronic kidney disease, Patients with chronic liver disease. Patients with hemostasis disorders, Patients with infections, Patients with a history of stroke.
 
KET-302/UN2.F1/ETIK/PPM.00.02/2023
MTA number
Not applicable
Rima Haifa, S.Si, M. Farm-Klin